Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman–Moore strain) manufactured in India

Zydus Cadila Health care, India developed a new purified chick embryo cell rabies vaccine (PCECV, Vaxirab-N; 1 mL) by adapting Pitman–Moore strain of virus on to the chick embryo fibroblast cell line in 2006. During 2007–10, a series of safety and immunogenicity studies were conducted as per ICH-GCP...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ashwath Narayana, Doddabele Hanumanthaiah, Madhusudana, Shampur Narayana, Sampath, Gadey, Tripathy, Radhe Madhab, Sudarshan, Mysore Kalappa, Gangaboraiah, Ravish, Haradanahalli Shankaraiah, Satapathy, Durga Madhab, Gowda, Giriyanna, Holla, Ramesh, Ashwin, Belludi Yajman, Padhi, Asutosh, Shamanna, Manjula, Patel, Pradip Maganlal
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2014
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4181025/
https://ncbi.nlm.nih.gov/pubmed/24030586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.26456
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars